Skip to content

A research study Looking into blood levels of the medicine NNC0519-0130 in the body of participants with normal or reduced kidney function

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506381-32-00
Acronym
NN9541-4923
Enrollment
36
Registered
2024-03-04
Start date
2024-03-25
Completion date
2024-11-27
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026